These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1257 related articles for article (PubMed ID: 25788569)
1. Low-dose human menopausal gonadotrophin versus clomiphene citrate in subfertile couples treated with intrauterine insemination: a randomized controlled trial. Peeraer K; Debrock S; De Loecker P; Tomassetti C; Laenen A; Welkenhuysen M; Meeuwis L; Pelckmans S; Mol BW; Spiessens C; De Neubourg D; D'Hooghe TM Hum Reprod; 2015 May; 30(5):1079-88. PubMed ID: 25788569 [TBL] [Abstract][Full Text] [Related]
2. Follicle stimulating hormone versus clomiphene citrate in intrauterine insemination for unexplained subfertility: a randomized controlled trial. Danhof NA; van Wely M; Repping S; Koks C; Verhoeve HR; de Bruin JP; Verberg MFG; van Hooff MHA; Cohlen BJ; van Heteren CF; Fleischer K; Gianotten J; van Disseldorp J; Visser J; Broekmans FJM; Mol BWJ; van der Veen F; Mochtar MH; Hum Reprod; 2018 Oct; 33(10):1866-1874. PubMed ID: 30137325 [TBL] [Abstract][Full Text] [Related]
3. Frozen-thawed embryo transfer in a natural or mildly hormonally stimulated cycle in women with regular ovulatory cycles: a RCT. Peeraer K; Couck I; Debrock S; De Neubourg D; De Loecker P; Tomassetti C; Laenen A; Welkenhuysen M; Meeuwis L; Pelckmans S; Meuleman C; D'Hooghe T Hum Reprod; 2015 Nov; 30(11):2552-62. PubMed ID: 26364081 [TBL] [Abstract][Full Text] [Related]
4. Effect of prematurely elevated late follicular progesterone on pregnancy outcomes following ovarian stimulation-intrauterine insemination for unexplained infertility: secondary analysis of the AMIGOS trial. Burks HR; Peck JD; Gavrizi S; Anderson ZS; Diamond MP; Hansen KR Hum Reprod; 2024 Aug; 39(8):1684-1691. PubMed ID: 38822675 [TBL] [Abstract][Full Text] [Related]
5. A randomized clinical trial of clomiphene citrate versus low dose recombinant FSH for ovarian hyperstimulation in intrauterine insemination cycles for unexplained and male subfertility. Dankert T; Kremer JA; Cohlen BJ; Hamilton CJ; Pasker-de Jong PC; Straatman H; van Dop PA Hum Reprod; 2007 Mar; 22(3):792-7. PubMed ID: 17110396 [TBL] [Abstract][Full Text] [Related]
6. Gonadotrophins for ovulation induction in women with polycystic ovary syndrome. Weiss NS; Kostova E; Nahuis M; Mol BWJ; van der Veen F; van Wely M Cochrane Database Syst Rev; 2019 Jan; 1(1):CD010290. PubMed ID: 30648738 [TBL] [Abstract][Full Text] [Related]
7. Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: a RCT. Moro F; Scarinci E; Palla C; Romani F; Familiari A; Tropea A; Leoncini E; Lanzone A; Apa R Hum Reprod; 2015 Jan; 30(1):179-85. PubMed ID: 25398971 [TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of ovarian stimulation agents for IUI in couples with unexplained subfertility. van Eekelen R; Wang R; Danhof NA; Mol F; Mochtar M; Mol BW; van Wely M Hum Reprod; 2021 Apr; 36(5):1288-1295. PubMed ID: 33615360 [TBL] [Abstract][Full Text] [Related]
9. Recombinant FSH increases live birth rates as compared to clomiphene citrate in intrauterine insemination cycles in couples with subfertility: a prospective randomized study. Erdem M; Abay S; Erdem A; Firat Mutlu M; Nas E; Mutlu I; Oktem M Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():33-7. PubMed ID: 25855325 [TBL] [Abstract][Full Text] [Related]
10. Gonadotrophins versus clomiphene citrate with or without IUI in women with normogonadotropic anovulation and clomiphene failure: a cost-effectiveness analysis. Bordewijk EM; Weiss NS; Nahuis MJ; Bayram N; van Hooff MHA; Boks DES; Perquin DAM; Janssen CAH; van Golde RJT; Lambalk CB; Goddijn M; Hompes PG; van der Veen F; Mol BWJ; van Wely M; Hum Reprod; 2019 Feb; 34(2):276-284. PubMed ID: 30576539 [TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of ovarian stimulation with gonadotrophin and clomiphene citrate in an intrauterine insemination programme for subfertile couples. Peeraer K; Luyten J; Tomassetti C; Verschueren S; Spiessens C; Tanghe A; Meuleman C; Debrock S; Dancet E; D'Hooghe T Reprod Biomed Online; 2018 Mar; 36(3):302-310. PubMed ID: 29395750 [TBL] [Abstract][Full Text] [Related]
12. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial. Drakopoulos P; Vuong TNL; Ho NAV; Vaiarelli A; Ho MT; Blockeel C; Camus M; Lam AT; van de Vijver A; Humaidan P; Tournaye H; Polyzos NP Hum Reprod; 2017 Nov; 32(11):2225-2233. PubMed ID: 29040589 [TBL] [Abstract][Full Text] [Related]
13. The pregnancy rates with intrauterine insemination (IUI) in superovulated cycles employing different protocols (clomiphen citrate (CC), human menopausal gonadotropin (HMG) and HMG+CC) and in natural ovulatory cycle. Mahani IM; Afnan M J Pak Med Assoc; 2004 Oct; 54(10):503-5. PubMed ID: 15552282 [TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of switching to gonadotrophins versus continuing with clomiphene citrate, with or without intrauterine insemination, in women with normogonadotropic anovulation and clomiphene failure: follow-up study of a factorial randomized clinical trial. Bordewijk EM; Jannink TI; Weiss NS; de Vries T; Nahuis M; Hoek A; Goddijn M; Mol BW; van Wely M; Hum Reprod; 2023 Mar; 38(3):421-429. PubMed ID: 36622200 [TBL] [Abstract][Full Text] [Related]
15. Ovarian stimulation strategies for intrauterine insemination in couples with unexplained infertility: a systematic review and individual participant data meta-analysis. Wessel JA; Danhof NA; van Eekelen R; Diamond MP; Legro RS; Peeraer K; D'Hooghe TM; Erdem M; Dankert T; Cohlen BJ; Thyagaraju C; Mol BWJ; Showell M; van Wely M; Mochtar MH; Wang R Hum Reprod Update; 2022 Aug; 28(5):733-746. PubMed ID: 35587030 [TBL] [Abstract][Full Text] [Related]
16. Expectant management versus IUI in unexplained subfertility and a poor pregnancy prognosis (EXIUI study): a randomized controlled trial. Wessel JA; Mochtar MH; Besselink DE; Betjes H; de Bruin JP; Cantineau AEP; Groenewoud ER; Hooker AB; Lambalk CB; Kwee J; Kaaijk EM; Louwé LA; Maas JWM; Mol BWJ; van Rumste MME; Traas MAF; Goddijn M; van Wely M; Mol F Hum Reprod; 2022 Nov; 37(12):2808-2816. PubMed ID: 36331493 [TBL] [Abstract][Full Text] [Related]
17. Is IVF-served two different ways-more cost-effective than IUI with controlled ovarian hyperstimulation? Tjon-Kon-Fat RI; Bensdorp AJ; Bossuyt PM; Koks C; Oosterhuis GJ; Hoek A; Hompes P; Broekmans FJ; Verhoeve HR; de Bruin JP; van Golde R; Repping S; Cohlen BJ; Lambers MD; van Bommel PF; Slappendel E; Perquin D; Smeenk J; Pelinck MJ; Gianotten J; Hoozemans DA; Maas JW; Groen H; Eijkemans MJ; van der Veen F; Mol BW; van Wely M Hum Reprod; 2015 Oct; 30(10):2331-9. PubMed ID: 26269539 [TBL] [Abstract][Full Text] [Related]
18. No difference in cycle pregnancy rate and in cumulative live-birth rate between women with surgically treated minimal to mild endometriosis and women with unexplained infertility after controlled ovarian hyperstimulation and intrauterine insemination. Werbrouck E; Spiessens C; Meuleman C; D'Hooghe T Fertil Steril; 2006 Sep; 86(3):566-71. PubMed ID: 16952506 [TBL] [Abstract][Full Text] [Related]
19. Birthweight and other perinatal outcomes of singletons conceived after assisted reproduction compared to natural conceived singletons in couples with unexplained subfertility: follow-up of two randomized clinical trials. Wessel JA; Mol F; Danhof NA; Bensdorp AJ; Tjon-Kon Fat RI; Broekmans FJM; Hoek A; Mol BWJ; Mochtar MH; van Wely M; Hum Reprod; 2021 Feb; 36(3):817-825. PubMed ID: 33347597 [TBL] [Abstract][Full Text] [Related]
20. Endometrial thickness as a biomarker for ongoing pregnancy in IUI for unexplained subfertility: a secondary analysis. Danhof NA; van Eekelen R; Repping S; Mol BWJ; van der Veen F; van Wely M; Mochtar MH; Hum Reprod Open; 2020; 2020(1):hoz024. PubMed ID: 31934648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]